Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine

• Status: Completed
• Trial end date: 2020-01-30
• Target enrollment: 0
• Participant gender: Male

Summary

The study is a drug trial comparing the post-operative pain control provided by liposomal bupivacaine (a local anesthetic) against standard bupivacaine (a different formulation of the local anesthetic) for men undergoing testicular sperm extraction.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Weill Medical College of Cornell University
• Collaborator: Pacira Pharmaceuticals, Inc
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Men scheduled for surgical sperm retrieval for infertility

• Men 18 years and older who can provide informed consent

• No documented allergy to bupivacaine or celecoxib

Exclusion Criteria:

• Prior history of substance abuse

• Any narcotic use within the last 3 months

• Concomitant use of aspirin

• Any of the following comorbidities: renal failure, heart disease, peptic ulcer disease, cerebrovascular disease, significant liver disease, untreated depression, chronic pain disorder, or bleeding diatheses

• Medical history or concurrent illness that the investigator considers sufficiently serious to interfere with the conduct, completion, or results of this trial, or constitutes an unacceptable risk to the subject